Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 65251 - 65275 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	MANSC1	54682	downregulated	resveratrol results in decreased expression of MANSC1 mRNA	12p13.2	A22289
Resveratrol	Investigational	MAP1A	4130	downregulated	resveratrol results in decreased expression of MAP1A mRNA	15q15.3	A23847
Resveratrol	Investigational	MAP1B	4131	downregulated	resveratrol results in decreased expression of MAP1B mRNA	5q13.2	A21103
Resveratrol	Investigational	MAP1LC3A	84557	downregulated	resveratrol results in decreased expression of MAP1LC3A mRNA	20q11.22	A22435
Resveratrol	Investigational	MAP1LC3B	81631	upregulated	resveratrol results in increased expression of MAP1LC3B mRNA	16q24.2	A23856
Resveratrol	Investigational	MAP2K1	5604	upregulated	resveratrol results in increased expression of MAP2K1 mRNA	15q22.31	A20482
Resveratrol	Investigational	MAP3K14	9020	downregulated	resveratrol results in decreased expression of MAP3K14 mRNA	17q21.31	A23852
Resveratrol	Investigational	MAP4	4134	downregulated	resveratrol results in decreased expression of MAP4 mRNA	3p21.31	A23847
Resveratrol	Investigational	MAPK13	5603	downregulated	resveratrol results in decreased expression of MAPK13 mRNA	6p21.31	A22289
Resveratrol	Investigational	MAPT	4137	downregulated	resveratrol results in decreased expression of MAPT mRNA	17q21.31	A23847
Resveratrol	Investigational	MARK2	2011	upregulated	resveratrol results in increased expression of MARK2 mRNA	11q13.1	A23852
Resveratrol	Investigational	MAT2A	4144	upregulated	resveratrol results in increased expression of MAT2A mRNA	2p11.2	A21103
Resveratrol	Investigational	MAT2B	27430	upregulated	resveratrol results in increased expression of and results in increased stability of MAT2B mRNA	5q34	A23930
Resveratrol	Investigational	MAT2B	27430	upregulated	resveratrol results in increased expression of MAT2B mRNA	5q34	A23930
Resveratrol	Investigational	MC1R	4157	downregulated	resveratrol results in decreased expression of MC1R mRNA	16q24.3	A21627
Resveratrol	Investigational	MCAM	4162	upregulated	resveratrol results in increased expression of MCAM mRNA	11q23.3	A23852
Resveratrol	Investigational	MCM4	4173	downregulated	resveratrol results in decreased expression of MCM4 mRNA	8q11.21	A23857
Resveratrol	Investigational	MCM6	4175	downregulated	resveratrol results in decreased expression of MCM6 mRNA	2q21.3	A23857
Resveratrol	Investigational	MDM2	4193	downregulated	resveratrol results in decreased expression of MDM2 mRNA	12q15	A23864 A23876 A23854
Resveratrol	Investigational	MDM2	4193	upregulated	resveratrol results in increased expression of MDM2 mRNA	12q15	A23859 A23857 A23852
Resveratrol	Investigational	MEF2C	4208	upregulated	resveratrol results in increased expression of MEF2C mRNA	5q14.3	A22498
Resveratrol	Investigational	MELK	9833	upregulated	resveratrol results in increased expression of MELK mRNA	9p13.2	A21103
Resveratrol	Investigational	MET	4233	upregulated	resveratrol results in increased expression of MET mRNA	7q31	A22289
Resveratrol	Investigational	METTL18	92342	upregulated	resveratrol results in increased expression of METTL18 mRNA	1q24.2	A21103
Resveratrol	Investigational	METTL7A	25840	upregulated	resveratrol results in increased expression of METTL7A mRNA	12q13.12	A23852

Displaying entries 65251 - 65275 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability